Vestal Point Capital »

Tectonic Therapeutic shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Tectonic Therapeutic (TECX) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Tectonic Therapeutic

Tip: Access up to 7 years of quarterly data

All positions including Tectonic Therapeutic held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tectonic Therapeutic by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.8M 328k 20.86

More positions owned by Vestal Point Capital

Abivax SA Sponsored Ads (ABVX)
Invesco QQQ Trust Series 1 Unit Ser 1 Put Option (QQQ)
Arcellx Common Stock (ACLX)
Terns Pharmaceuticals (TERN)
BioMarin Pharmaceutical (BMRN)
Globus Medical Cl A (GMED)
Nurix Therapeutics (NRIX)
Alcon Ord Shs (ALC)
Dex (DXCM)
Merck & Co (MRK)
Taysha Gene Therapies Com Shs (TSHA)
Abbott Laboratories (ABT)
Immatics NV SHS (IMTX)
Tyra Biosciences (TYRA)
Bicara Therapeutics (BCAX)

View all positions for Vestal Point Capital

Top funds holding Tectonic Therapeutic

FMR
Standard Life Aberdeen
Braidwell
BlackRock
5AM Venture Management
Vanguard Group
Point72 Asset Management
Vestal Point Capital
Bollard
Citadel Advisors
Geode Capital Management
Pale Fire Capital SE
Susquehanna International
Millennium Management
Prosight Management

View all funds holding Tectonic Therapeutic